On the Continent, "diuresis" can be taken as synonymous with urine flow-rate; whereas in this country and in America it implies an increase in urine flow, either "spontaneous" or in response to a stimulus. It may be worth while to keep both these definitions in mind; for an understanding of the factors which normally determine urine flow is helpful in seeing when these are deficient in disease, and in devising substitute-mechanisms to replace them.
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On the Continent, "diuresis" can be taken as synonymous with urine flow-rate; whereas in this country and in America it implies an increase in urine flow, either "spontaneous" or in response to a stimulus. It may be worth while to keep both these definitions in mind; for an understanding of the factors which normally determine urine flow is helpful in seeing when these are deficient in disease, and in devising substitute-mechanisms to replace them.
On current theories of renal function, we can distinguish three main determinants of urine flow-rate.
(1) The "filtered load" of water and solutes, which greatly exceeds the urine volume, but which can be significantly depressed when the renal circulation is reduced.
(2) The "facultative reabsorption" of water in the distal tubule, whose rate is mainly controlled by the anti-diuretic hormone of the posterior pituitary, but is also influenced by cortisone in patients with adrenal insufficiency.
(3) The tubular reabsorption of sodium and its associated anions which is enhanced by aldosterone.
Borst and deVries (1950) distinguished three forms of "natural diuresis"-water diuresis, osmotic diuresis, and the diurnal variations in urine-flow. Many of us think that diurnal variation may be a special case of osmotic diuresis (Stanbury and Thomson, 1951) . The distinction between water diuresis and osmotic diuresis is an important one in practice; our object in diuretic treatment is to eliminate solutes from the body as well as water, and this will not be achieved by inducing a pure water diuresis. In a water diuresis, the concentration of solutes in the urine falls off with increasing urine volume until the specific gravity of the urine is almost that of water; the rate of solute excretion changes little if at alL In an osmotic diuresis, induced by a "loading solute" such as mannitol or urea, the concentration of total solutes also decreases with increasing urine volume, but falls only to a level comparable to the solute concentration in plasma; the rate of solute excretion increases, as it must do to eliminate the imposed load of solute.
Oliguria in itself is not an indication for the use of conventional diuretic agents. When oliguria is related to acute renal failure, diuretic drugs are ineffective and may be harmfuL When oliguria is due to inadequate renal blood-flow, the prime indication is to restore the circulation by transfusion of blood or plasma in surgical shock; by giving sodium-containing solutions in sodium depletion; and by rest and general treatment in cardiac failure. Oliguria due to maximal water reabsorption under the influence of A.D.H. is usually transient, and does not lead to significant solute retention; oliguria in adrenal insufficiency, anemia, and steatorrhoea responds to effective treatment of the primary disease, and does not require diuretics.
The real indication for treatment with diuretics is a combination of oliguria and cedema, which implies retention of solutes, namely sodium and its accompanying anions. With this is retained enough water to prevent increase in the osmolarity of extracellular fluid; this secondary increase in body water. is accomplished partly by the thirst mechanism and partly by A.D.H. The clinical situation may be further complicated by hypoproteinaemia or urea retention; but the abnormality most susceptible to diuretic treatment is the retention of sodium. To get rid of this, we must induce an osmotic diuresis, either by increasing the filtered load of sodium, or indirectly by decreasing the tubular reabsorption of sodium.
The filtered load of sodium can be increased by any measure which increases renal plasma flow, and the xanthine diuretics probably act in this way: the osmotic diuretics, such as mannitol, dextran, and urea may also increase sodium filtration, though their main action is to depress tubular reabsorption of sodium. Salt-free albumin infusions increase the filtered load of sodium effectively, but transiently; a high-protein diet is more practicable, but less effective.
The most effective group of diuretics which we possess, the organic mercurials, do not appreciably affect the filtered load of sodium; but they partly inhibit sodium reabsorption, not directly, but by inhibiting chloride reabsorption. Increase in anion excretion can also be effected by the carbonic anhydrase inhibitors, and by acidifying salts such as ammonium chloride.
In the ensuing discussion, I have little doubt that the limitations as well as the usefulness of currently available diuretics will be stressed. Failure to achieve diuresis and resolution of cedema is no doubt often due to the renal circulation being hopelessly compromised by SEPTEMBER cardiac failure; but sometimes the renal tubules seem to be reabsorbing sodium with abnormal avidity under the influence of aldosterone. Even adrenalectomy has been resorted to in obstinate cedema; but the future may bring some less desperate method of preventing aldosterone production, or of blocking its action on sodium reabsorption. REFERENCES BORST, J. G. G., and DEVRIES, L. A. (1950) Lancet, ii, 1. STANBURY, S. W., and THOMSON, A. E. (1951) Clin. Sci., 10, 267.
Dr. T. Hanley: The Diuretic Action of Acetazolamide Acetazolamide (the official name for "Diamox") is a powerful inhibitor of the enzyme carbonic anhydrase (Miller, et al., 1950) . It is believed that the renal tubule cells reabsorb "bicarbonate-bound base" by exchanging sodium ions contained in the glomerular filtrate for hydrogen ions which have been formed within the cells from carbon dioxide hydrated under the catalytic influence of this enzyme (Pitts and Alexander, 1945) . Inhibition of carbonic anhydrase thus causes excretion of a proportion of the "filtered load" of bicarbonate, and the diuretic action of acetazolamide is largely dependent on the osmotic effect of this augmented excretion of bicarbonate. When the drug is administered in therapeutic dosage (0 25 to 1 0 gram) at intervals of twenty-four hours or more frequently, its action is transient.
By the third or fourth day the acid-base composition of the urine returns to normal, bicarbonate excretion ceases and no further diuresis occurs. This diminishing effect limits very considerably the therapeutic effect of the drug. It appears probable that the development of "resistance" to the action of acetazolamide is induced automatically by the fall of plasma bicarbonate concentration which results from loss of bicarbonate in the urine Hanley and Platts, 1956) . Complete "resistance" to the drug's action is associated with reduction of the load of bicarbonate filtered by the glomeruli to about 75 % of the initial level, and this occurs when approximately 200 milli-equivalents of bicarbonate have been lost in the urine. Continued administration of the drug beyond this point will maintain depression of the plasma bicarbonate and a systemic acidosis, but will not cause any further urinary excretion of bicarbonate.
In a clinical trial of acetazolamide on 18 patients with congestive heart failure of various oetiology Hanley and Platts (1956) observed a good therapeutic effect in only 3 instances, and the remaining 15 patients were still cedematous after several days of treatment with acetazolamide (0-25 to 10 gram daily or on alternate days). Comparison of the diuretic effect of mersalyl B.P. and acetazolamide on 15 of these persons showed that, in general, the mercurial diuretic caused a much larger increment of sodium and water excretion and a considerably greater reduction of aedema and venous pressure than did acetazolamide. The carbonic anhydrase inhibitor was also administered to 12 patients who had recently recovered from an attack of congestive heart failure and who were free from aedema when therapy was begun. 5 of these 12 patients again developed aedema and venous congestion within four to eight weeks. No serious toxic symptoms were observed in any patient, although many complained of drowsiness, headache and paresthesie. There was no clinical evidence of potassium deficiency even in those patients treated for continuous periods of a few months to one year. The general conclusion was reached that acetazolamide compares unfavourably with the mercurial diuretics in the treatment of congestive heart failure, and that reliance should not be placed on acetazolamide alone for relief of aedema. Occasionally a good therapeutic result may be obtained from the drug but it does not seemn possible to predict on which patients this will occur. Acetazolamide may, however, prove to be an effective adjuvant to mersalyl therapy by correcting the hypochloremia which is, in some instances, associated with "resistance" to mercurials, and this aspect of the drug's action merits further investigation. In the prophylaxis of cardiac cedema acetazolamide has not proved to be very effective, and it seems improbable that it will supplant the wellestablished mercurial diuretics in this respect. tive differences in the action of these diuretic drugs (Table 1 ). The concentration of chloride in plasma is almost four times as great as that of bicarbonate, and therefore the glomerular filtrate contains considerably more chloride than bicarbonate. The maximal diuretic effect of mercurials results in an excretion of only 20% of the filtered chloride (Duggan and Pitts, 1949) , and similarly, therapeutic doses of acetazolamide produce a maximum rate of bicarbonate excretion of 25% of the amount filtered . Consequently, mercurial diuretics are potentially three times more effective than acetazolamide (Table I) . Plasma chloride x glomerular filtration rate = amount of chloride filtered at the glomeruli each minute. 0-1 mEq./ml. x 120 ml./min. = 12 0 mEq. Cl/min. Maximum excretion rate after a mercurial injection is 20% of filtered chloride = 2-4 mEq. Cl/min. Plasma bicarbonate x glomerular filtration rate. = amount of bicarbonate filtered at the glomeruli each minute. 0-027 mEq./ml. x 120 ml./min. = 3-24 mEq. bicarbonate/min. Maximum excretion rate after ingestion of a therapeutic dose of acetazolamide is 25 % of filtered bicarbonate. = 0 81 mEq. bicarbonate/min.
Therefore the maximum effect of a mercurial is about three times the maximum effect of acetazolamide.
The increase of urinary anion necessarily results in a corresponding rise of urinary cation, which is almost entirely sodium and potassium in varying proportion. Increased output of sodium is beneficial, but potassium loss is an undesirable complication of diuretic therapy. Secondary potassium depletion is particularly harmful in congestive heart failure since it increases digitalis toxicity (Lown et al., 1951) . The higher the proportion of sodium excreted in relation to potassium, the more efficient is the diuretic agent. Significant potassium loss is found in states of "secondary aldosteronism" where there is a stimulus to the adrenals to secrete excess aldosterone. This occurs after dietary sodium depletion or increased potassium intake, and in severe congestive heart failure, cirrhosis of the liver with ascites, and the nephrotic syndrome with massive oedema (Luetscher and Curtis, 1955) . Representative values of the proportions of sodium and potassium output after acetazolamide and mercurial diuretics are given in Table II (data from paper of Counihan et al., 1954) . It is 270% Zero 100% seen that the proportion of potassium is invariably higher after acetazolamide than after mercurials. Acetazolamide produces an alkaline urine which favours excess potassium exchange for sodium (Berliner et al., 1951) . The greatest potassium loss occurs in grave congestive heart failure with severe secondary aldosteronism. Acetazolamide in such cases may cause an increased output of potassium bicarbonate alone, no excess sodium being eliminated. This may be misleading if the efficiency of the diuretic is assessed solely by increase of urinary volume without analyses of urinary sodium and potassium. Similar results have been reported in cases of the nephrotic syndrome (Metcoff et al., 1955) , and in hepatic cirrhosis with ascites (Hecker, 1956) . Potassium deficiency can be avoided by the routine use of potassium supplements in all patients receiving regular diuretic therapy.
Potassium chloride should be used with mercurials, and potassium bicarbonate or citrate with acetazolamide.
Both mercurial diuretics and acetazolamide have a self-limiting action due to alteration in plasma composition. Mercurials cause a reduction of plasma chloride with increase of plasma bicarbonate, i.e. a hypochlorxmic alkalosis. Acetazolamide has the opposite effect with production of a hyperchlornmic acidosis. The single greatest disadvantage of acetazolamide as a diuretic lies in the difficulty of correcting the acidosis with restoration of the diuretic effect. Administration of sodium bicarbonate would defeat the object of therapy, i.e. elimination of sodium. The use of potassium bicarbonate is also ineffective since potassium exchange for sodium is increased with consequent excretion of potassium bicarbonate rather than sodium bicarbonate. In contrast, there are three methods of correction of the hypochlorxmic alkalosis produced by mercurials and thus the diuretic effect can be maintained. Ammonium chloride, cation exchange resins in the ammonium cycle, and acetazolamide itself, all produce an acidosis with increase of plasma chloride and are therefore valuable adjuvants to mercurial diuretics. Acetazolamide is more useful as a means of potentiating the action of mercurials than as a diuretic in its own right. As a general rule, the effect of mercurials is roughly proportional to the amount of chloride filtered at the glomeruli, i.e. the product of plasma chloride and glomerular filtration rate. The plasma chloride can be increased by use of ammonium chloride, exchange resins, or acetazolamide as already described. The patient may still, however, prove refractory to mercurials if the glomerular filtration rate is grossly reduced, as in severe congestive heart failure. In such cases sensitivity may sometimes be restored by intravenous aminophylline which causes a temporary increase of glomerular filtration rate (Vogl and Esserman, 1951) . Aminophylline at a maximum dose of 0-5 gram intravenously is best given about two hours after the intramuscular injection of the mercurial when the greatest synergistic action is obtained. Mersalyl contains some aminophylline but in insufficient amount to provide this particular effect. Mudge and Hardin (1956) have recently described an important exception to the general rule that the effect of mercurials is roughly proportional to the amount of chloride in the glomerular filtrate. They found that an excellent diuresis occurred in potassium depletion with hypokalxmic alkalosis and low plasma chloride. The renal tubular cells in potassium depletion are abnormally acidic (Anderson and Mudge, 1955) , and it was thought that intracellular acidity increases the dissociation of mercury and thus potentiates the diuretic effect.
Mercurial diuretics are relatively non-toxic even when given for prolonged periods. One patient is known to have received 627 injections in twelve years without showing any evidence of toxic effect (Friedenson, 1944) . Two cases are recorded who had received large doses of mercurials at weekly intervals for many years without any renal damage or biochemical evidence of retention of mercury being found at necropsy (Schroeder, 1951) . Normally, 75 % to 95 % of the mercury is excreted within the first twenty-four hours after injection, and elimination is virtually complete within three days (Burch et al., 1950) . Toxic effects from accumulation of mercury will therefore occur only in patients showing inefficient and delayed excretion. This may be found in cases with gross reduction of the glomerular filtration rate and increase of blood urea, and in refractory individuals without a significant diuretic response. Mercurials are therefore contra-indicated in urxmia and in patients who are consistently refractory despite administration of the adjuvants previously described. A large proportion of the mercury temporarily accumulates in the outer parts of the renal cortex (Greif et al., 1956) , and therefore renal damage may occasionally occur. Proteinuria and oliguria with increasing uremia are the most common signs of renal damage. Dimercaprol (BAL) is useful in preventing further damage and increasing the rate of mercury excretion. Munck and Nissen (1956) have recently claimed that organic mercurials can occasionally cause a true nephrotic syndrome. No evidence of accumulation of mercury was obtained in the four cases described, and therefore the evidence is incomplete. Mercurial diuretics are piot necessarily contra-indicated in patients with proteinuria. Many cases of congestive heart failure are complicated by proteinuria which often disappears with therapy. Increasing urinary protein loss is, however, a sign of renal damage and an indication to stop diuretic therapy.
